Home / Gastroenterology / Chronic Liver Disease Care
Gastroenterology patient guide · 慢性肝病诊疗

Chronic Liver Disease Care in China

Considering chronic liver disease care in China? Start with liver reports, ongoing treatment and review goals. This guide helps you identify the relevant records, questions for the receiving team and the scope of an individual estimate before a visit is agreed.

Chinese hepatologist explaining chronic liver disease stages to an international patient

Medical records & cost enquiry

Chronic Liver Disease Care: assessment and cost questions

For Chronic Liver Disease Care, the budget depends on the proposed care and the hospital. A useful estimate needs to distinguish:

  • Cause and current stage of liver disease
  • Investigations and treatment proposed
  • Medicines and ongoing monitoring

Hospital medical fees, travel and our coordination services are separate. Any paid specialist review or coordination service is explained and agreed before you proceed.

Your next step

Start with your question

Tell us your diagnosis and what you need. Our free initial review checks the information and helps identify a suitable next step; it is not a specialist opinion or a hospital quotation.

Request a case-based estimate

Not ready to send records? Ask us first. Where hospital review is appropriate, we can help request an estimate. No travel commitment or mandatory proxy consultation.

Planning chronic liver disease care in ChinaHospital review · individual costs · visit and follow-up

Plan the visit around liver reports, ongoing treatment and review goals. Agree the assessment route before travel.

Records for the chronic liver disease care review

Tell us what you already have: Complete liver blood-test trends; Hepatitis autoimmune and metabolic investigations; Ultrasound CT MRI and elastography. Start with a short summary; after first contact we explain which records the receiving team needs and how to share them.

Confirm the proposed scope and costs

Before asking for a personal estimate, clarify: Cause and current stage of liver disease; Investigations and treatment proposed; Medicines and ongoing monitoring. The receiving team confirms the proposed scope and hospital charges; coordination is agreed separately.

Visits and care after returning home

Explain the current diagnosis and medicines, and ask how specialist findings would be handed over for ongoing care at home. Tell us if you need interpretation or English-language documents, and confirm the relevant arrangements with the receiving team.

Chronic liver disease care combines cause control with complication prevention

Long-term injury from viral hepatitis, metabolic liver disease, alcohol, autoimmune disease, bile-duct disease or inherited conditions can lead to fibrosis and cirrhosis.

A patient may feel well despite significant scarring. Blood tests, imaging, elastography and clinical signs help determine whether the liver remains compensated or has developed portal hypertension or failure.

A normal enzyme level does not prove a healthy liver

Stage and function depend on the whole pattern: platelets, bilirubin, albumin, clotting, imaging, stiffness and complications.

Who may be considered?

Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about chronic liver disease assessment and care.

  • Persistent abnormal liver tests or known chronic hepatitis.
  • Fatty or metabolic liver disease with suspected fibrosis.
  • Cirrhosis needing complication surveillance.
  • Ascites, variceal bleeding, confusion or jaundice requiring specialist management.

What the specialist team must confirm

Review includes cause-specific blood tests, alcohol and medicine history, metabolic risk, ultrasound CT or MRI, elastography, blood count, INR, albumin, bilirubin, kidney function, portal-hypertension signs, previous biopsy and screening history for varices and liver cancer.

Key points for this treatment

First questioncause of ongoing liver injury
Stagefibrosis cirrhosis and compensation
Complicationsfluid bleeding confusion and cancer
Carecause treatment plus surveillance
Chinese liver multidisciplinary team reviewing elastography ultrasound blood tests and portal hypertension findings
Cause and stage create the care planAntiviral, metabolic, autoimmune or alcohol-related treatment is paired with surveillance and management of portal-hypertension complications.

From cause identification to lifelong risk management

The team aims to slow further damage, detect complications early and refer for transplant assessment before irreversible decline becomes an emergency.

IdentifyDefine cause and reversible injury
StageMeasure fibrosis function and portal pressure signs
TreatControl cause and complications
SurveilMonitor varices cancer and decompensation

Trends matter more than one laboratory result

Weight, symptoms, alcohol exposure, medicines, blood tests and liver stiffness are reviewed over time. Patients with cirrhosis may need regular cancer imaging and variceal assessment.

New fluid retention, confusion, infection, bleeding or kidney decline changes prognosis and may accelerate transplant evaluation.

International patient discussing medicines nutrition and liver cancer surveillance at follow up
Compensation can changeA first episode of ascites, variceal bleeding or encephalopathy is an important transition that requires prompt specialist reassessment.
Cause controlledContinue stage-based surveillance
Fibrosis progressesEscalate risk modification
DecompensationTreat complications and assess transplant
Stable cirrhosisMaintain cancer and variceal screening

Risks, limits and realistic expectations

Scarring may not fully reverse. Medicines, procedures and lifestyle changes reduce risk but cannot guarantee prevention of liver failure or cancer. Decompensated disease can deteriorate rapidly.

Do not delay urgent local care

Vomiting blood, black stool, confusion, fever with abdominal swelling, severe jaundice, fainting or reduced urine output requires emergency local care.

Before hospital review

Records for chronic liver disease care assessment

A safe international review depends on dated source reports, original imaging and a complete treatment timeline—not a diagnosis label alone.

Complete liver blood-test trends
Hepatitis autoimmune and metabolic investigations
Ultrasound CT MRI and elastography
Endoscopy and variceal-treatment reports
Liver biopsy pathology if performed
Ascites encephalopathy and admission history
Alcohol medicine supplement and weight history
Cancer surveillance and transplant assessments

Tell us what you need

Ask about your care,
your hospital and your budget.

You can ask about suitability, an expert opinion, an appointment or the likely medical cost. If you are unsure, choose “Not sure — please advise”.

This enquiry is aboutChronic Liver Disease CareNot sure — please advise

How a personal estimate is prepared

  1. Tell us about your case.Describe your diagnosis, main question and preferred city, if any.
  2. Share the relevant records.We explain what is needed and how to send it by WhatsApp or email.
  3. Request a hospital estimate.Where appropriate, we help request hospital review and a cost estimate. Any paid review is agreed first.

This is an enquiry, not an order or payment. Proxy consultation is not mandatory. Any service scope is agreed separately before you proceed.

Ask about Chronic Liver Disease Care

A first enquiry is free. Email and permission to respond are required; the other details are optional. Any paid clinical review or coordination is discussed separately.

Included automatically so we know which procedure you are asking about.
A preference, not a confirmed appointment.
Please do not send passport numbers, card details or full medical files in this first enquiry. We will explain which records are needed next.

Send a short summary first. This is an enquiry, not an order, payment or confirmed appointment.

No booking or payment is made by sending this enquiry.
Editorial transparency

Medical sources

Patient information is based on established government and professional guidance. Content updated 5 October 2026. This is patient information, not an individual clinical assessment.